PSA on
PSA
A Public Service Announcement on the Prostate-Specific Antigen Test
Prostate cancer is treatable when caught early. Start the conversation and help others do the same.
Prostate cancer is treatable when caught early. Start the conversation and help others do the same.
PSA on PSA is Cleveland Diagnostics’ annual prostate cancer awareness campaign. Short for “A Public Service Announcement on the Prostate-Specific Antigen Test,” the campaign helps men and their loved ones better understand prostate cancer risk and begin informed conversations about screening and testing options.
This year, PSA on PSA is expanding the conversation through partnerships with Michigan Men’s Health and ZERO Prostate Cancer. Together, we are connecting men and their families with trusted experts, practical information, and resources that can help them take a more active role in their health.
Knowing what to ask can help start an important conversation. Download our factsheet for information on prostate cancer risk, PSA screening, follow-up testing, and questions for your doctor.
For every factsheet downloaded during Prostate Cancer Awareness Month this September, Cleveland Diagnostics will donate to ZERO Prostate Cancer to support patient education, advocacy, and research. ZERO will match all donations, doubling the impact of every download.
Cleveland Diagnostics and Michigan Men’s Health are partnering on a limited video series featuring candid conversations with leaders in urology, prostate cancer, mental wellness, and men’s health.
Hosted by Michigan Men’s Health founder Dr. Michael Lutz, new episodes will be released weekly throughout September. The series will explore the issues that influence whether men seek care and talk openly about their health—including fear, access to care, mental wellness, prostate cancer risk, screening, and innovation.
The series supports the shared PSA on PSA mission: making credible health information easier to access and important conversations easier to begin.
Cleveland Diagnostics is a precision oncology company working to unlock the diagnostic power of protein structure.
Through its IsoClear™ platform, Cleveland Diagnostics develops novel diagnostics designed to provide deeper biological insights using tests that can be performed within the clinical laboratory.
Our commitment extends beyond diagnostic innovation. Through PSA on PSA and our partnerships with Michigan Men’s Health and ZERO Prostate Cancer, we are helping connect men and their families with credible information, trusted experts, and resources that support more informed healthcare conversations.